Europe Medical Cannabis Market Expected to Reach USD 12,652.9 Million by 2033 - IMARC Group

January 13, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

Europe Medical Cannabis Market Statistics, Outlook and Regional Analysis 2025-2033

The Europe medical cannabis market size was valued at USD 2,586.1 Million in 2024, and it is expected to reach USD 12,652.9 Million by 2033, exhibiting a growth rate (CAGR) of 18.33% from 2025 to 2033.

Europe Medical Cannabis Market

To get more information on this market, Request Sample

The market in Europe has shifted significantly due to its increased legalization. Additionally, more countries in the region are passing legislation to allow its use, resulting in a regulatory development that provides strict quality control, safety requirements, and patient accessibility. Nations such as Germany, the United Kingdom, and Italy have established complete frameworks that include license systems for cultivation, production, and distribution. In April 2024, Germany authorized restricted adult cannabis use, allowing home cultivation of up to three plants per household and personal possession of up to 25 grams. The new law also simplifies access to medical cannabis and establishes "cultivation social clubs" for recreational usage. Besides this, Germany will investigate commercial supply networks via pilot projects before the 2025 elections.

Additionally, technological improvements are transforming the market by enhancing cultivation, extraction, and product composition. Precision agriculture, hydroponics, and advanced greenhouse technology have improved the quality and productivity of cannabis plants. In extraction techniques, supercritical CO₂ and other cutting-edge methods boost cannabinoids' purity and potency, resulting in reliable and effective products. These technological breakthroughs in cultivation and extraction are expanding the market by improving product quality and variety. In July 2024, Cannatrol announced a partnership with Paralab Green to bring its unique Vaportrol® Technology to Europe. This collaboration introduced Cannatrol's innovative dry, cure, and storage solution to cannabis producers, promising improved product quality, higher yields, and GMP regulatory compliance. Paralab Green, a well-known distributor in the region, helped with distribution. Besides this, the growing demand for cannabidiol (CBD) products is driven by their medicinal benefits, which are free of the euphoric effects of THC, resulting in wider acceptability and use. CBD’s legal status in some European countries contributes to regional market expansion. As consumers become more aware of the health advantages of CBD, they are adopting CBD-infused products into their daily routines. This trend is encouraging market innovation and expansion as a wider range of CBD products becomes available. For example, in February 2024, Zerion Pharma A/S collaborated with dsm-firmenich to improve cannabis bioavailability for medical and nutritional applications.

Europe Medical Cannabis Market Statistics, By Country

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Germany, France, the United Kingdom, Italy, Spain, and others. According to the report, Germany acquired the largest market share owing to its strong healthcare infrastructure and regulatory frameworks.

Germany Medical Cannabis Market Trends:

The dominance of Germany across the market is pushed by an optimal insurance reimbursement system, which allows for widespread patient access. More than 128,000 people undergo cannabis therapies, with statutory health insurance covering the costs. This policy increases demand and encourages physician prescriptions. Companies such as Aurora and Tilray have expanded operations to meet Germany's demands.

France Medical Cannabis Market Trends:

The government's support drives the growth of medical cannabis in France. In January 2025, the healthcare officials in France extended the experimental program until July 2025. The extension reflects the government’s commitment to thoroughly evaluate the potential of cannabis-based treatments for conditions like chronic pain and epilepsy.

United Kingdom Medical Cannabis Market Trends:

The rise of private clinics, which avoid NHS prescription problems, is driving growth in the United Kingdom. Clinics such as Sapphire Medical provide streamlined access for chronic pain and anxiety patients, garnering over 15,000 active users. Furthermore, pharmaceutical innovation from companies, including GW Pharmaceuticals, drives the demand for cannabis in the UK.

Italy Medical Cannabis Market Trends:

The rising government-coordinated imports across Italy are escalating the demand for cannabis. To accommodate patient demand, the Ministry of Defense cultivates domestically. The government intends to expand farming to alleviate chronic supply shortages which is further stimulating the market demand.

Spain Medical Cannabis Market Trends:

Regulatory changes support the demand for medical cannabis in Spain. For example, the Health and Consumer Affairs Commission advocated medical cannabis regulation to fill therapeutic gaps for patients who do not respond to traditional medicines. Building on this, the Ministry of Health issued a draft royal decree for public consultation in late 2023, with the goal of ensuring access to standardized cannabis treatments.

Other Medical Cannabis Market Trends:

Portugal, Denmark, and Poland drive growth through export-oriented cultivation. Portugal leads with companies like Tilray exporting to Germany and beyond, leveraging its favorable climate. Denmark’s pharmaceutical-grade cannabis cultivation attracts investors, further escalating the market growth.

Top Companies Leading in the Europe Medical Cannabis Industry

The competitive landscape of the Europe medical cannabis market is marked by prominent organizations that dominate the region. The Europe medical cannabis market is extremely competitive, with several prominent companies dominating the market landscape. They nowadays rely on strong research and development (R&D) capabilities, strategic collaborations, and robust distribution networks to sustain market leadership. Emerging local firms are gaining traction by focusing on particular markets and following strict European laws.

Europe Medical Cannabis Market Segmentation Coverage

On the basis of the species, the market has been bifurcated into indica, sativa, and hybrid. Among these, indica represented the largest segment. Indica is a plant species indigenous to the Hindu Kush highlands of Southern Asia. It belongs to the Cannabaceae family and grows as an annual plant. It can be widely used in treating various medical conditions.
Based on the derivative, the market is categorized into cannabidiol (CBD), tetrahydrocannabinol (THC), and others, amongst which tetrahydrocannabinol (THC) accounted for the most prominent share. Tetrahydrocannabinol (THC) is a colorless and oily chemical found in cannabis. It is the psychoactive component of cannabis. Moreover, it is known for its analgesic and anti-inflammatory properties, making it an important tool for treating chronic pain, nausea, appetite loss, and some neurological conditions.
On the basis of the application, the market has been divided into cancer, arthritis, migraine, epilepsy, and others. Among these, cancer represented the largest segment. The increasing prevalence of cancer across Europe is stimulating the segment's growth. Medical cannabis, particularly THC and CBD-rich strains, is extensively used to treat cancer-related symptoms like chronic pain and loss of appetite.
On the basis of the end use, the market has been bifurcated into the pharmaceutical industry, research and development centers, and others. Among these, the pharmaceutical industry acquired the most prominent share. Leading pharmaceutical firms are producing cannabis-based drugs, ensuring high-quality goods. Also, partnerships and collaborations with biotech enterprises and research organizations are escalating the segment's growth.
Based on the route of administration, the market is categorized into oral solutions and capsules, smoking, vaporizers, topicals, and others, amongst which oral solutions and capsules represent the largest segment. The oral solutions and capsules are especially popular among patients suffering from chronic illnesses, including pain and epilepsy, who require controlled and continuous cannabinoid release.

Report Features	Details
Market Size in 2024	USD 2,586.1 Million
Market Forecast in 2033	USD 12,652.9 Million
Market Growth Rate 2025-2033	18.33%
Units	Million USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Species Derivative Application End Use Route of Administration Country
Species Covered	Indica, Sativa, Hybrid
Derivatives Covered	Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others
Applications Covered	Cancer, Arthritis, Migraine, Epilepsy, Others
End Uses Covered	Pharmaceutical Industry, Research and Development Centers, Others
Route of Administration Covered	Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, Others
Countries Covered	Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Browse IMARC Related Reports on Medical Cannabis Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Europe Medical Cannabis Market Expected to Reach USD 12,652.9 Million by 2033 - IMARC Group

Purchase Options New Year Sale

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.